Here's the truth: NO RISK for IPIX, yet their first drug will be taken through clinical trials and marketing, with money coming in for them at each stage of development, and then royalties.

To reiterate:
IPIX has NO risk whatsoever, and gets money when someone ELSE pays out money for their drug to get developed.

All this whining about "ooh ooh we don't know the proprietary information" -- and yet magically they forget that there are millions of dollars in value by having someone ELSE pay for the clinical trial.

And in the meantime, IPIX continues developing their other drugs -- using money from this deal.

I wonder, should I put in another order for more stock? Oh yeah.... I ALREADY HAVE.